Immunomodulatory-based therapy as a potential promising treatment strat- egy against severe covid-19 patients: A systematic review
The global panic of the novel coronavirus disease 2019 (COVID-19) triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an urgent requirement for effective therapy. COVID-19 infection, especially in severely ill patients, is likely to be associated with immune dysr...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12765
- Acceso en línea:
- https://doi.org/10.1016/j.intimp.2020.106942
http://hdl.handle.net/20.500.12010/12765
- Palabra clave:
- COVID-19
SARS-CoV-2
Immunomodulatory-based therapy
Passive immunotherapy
Cytokine-targeted therapy
Mesenchymal stem cells
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido